Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial

JAMA Neurol. 2018 Mar 1;75(3):379-381. doi: 10.1001/jamaneurol.2017.4211.

Babak B Navi^{1

2

3}, Randolph S Marshall⁴, Dylan Bobrow³, Samuel Singer³, Jacqueline B Stone³, Maria T DeSancho⁵, Lisa M DeAngelis^{1

2

3}

¹ Department of Neurology, Weill Cornell Medicine, New York, New York.
² Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York.
³ Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
⁴ Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York.
⁵ Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York.

Abstract

This randomized clinical trial compares anticoagulation vs antiplatelet therapy in patients with cancer and acute ischemic stroke.